Nutrient deficiencies Appetite suppression could lead to reduced calorie and nutrient [] Understanding GLP-1 Medications: Insights from a Patient Interview GLP-1 receptor agonists like semaglutide have become a game-changer in weight management, particularly for individuals struggling with conditions like PCOS (polycystic ovary syndrome) and insulin resistance
In 2019, an oral version of semaglutide, marketed under the brand name Rybelsus, was also approved for managing type 2 diabetes (T2D)
Unlike pure GLP-1 compounds that work primarily through appetite reduction, Retatrutide actively increases energy expenditure
The GLP-1 receptor agonists work by mimicking the GLP-1 hormone in the gut, and the dual agonists work by mimicking both the GLP-1 and GIP hormones, which regulate blood glucose and appetite
Wear for up to 8 hours, then replace with a new patch
Prez-Torres I, Manzano-Pech L, Rubio-Ruz ME, Soto ME, Guarner-Lans V